Regeneron Pharmaceuticals Inc. buy TD Cowen
Summary
This prediction is currently active. The BUY prediction by TD_Cowen is currently unchanged from the start price. This prediction currently runs until 23.04.27. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Regeneron Pharmaceuticals Inc. | 0.00% |
| iShares Core DAX® | -0.201% |
| iShares Nasdaq 100 | 2.573% |
| iShares Nikkei 225® | 0.598% |
| iShares S&P 500 | 1.804% |
Comments by TD_Cowen for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Stopped prediction by TD_Cowen for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
23.07.24
23.07.25
24.07.25
Regeneron Pharmaceuticals Inc.
24.04.24
24.04.25
25.04.25
Regeneron Pharmaceuticals Inc.
06.12.23
06.12.24
07.12.24

